Invesco Ltd. Neuro Bo Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$2.74 - $4.63 $30,553 - $51,629	-11,151 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.93 - $6.68 $1,147 - $1,950	292 Added 2.69%	11,151 $49,000
Q4 2020 Feb 16, 2021	BUY	$5.02 - $6.59 $54,512 - $71,560	10,859 New	10,859 $57,000

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.